FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2647184575> ?p ?o ?g. }

• W2647184575 endingPage "e0179509" @default.
• W2647184575 startingPage "e0179509" @default.
• W2647184575 abstract "Acute heart failure (AHF) is the most common primary diagnosis for hospitalized heart diseases in Africa. As increased fatty acid β-oxidation (FAO) during heart failure triggers detrimental effects on the myocardium, we hypothesized that trimetazidine (TMZ) (partial FAO inhibitor) offers cardioprotection under normal and obese-related diabetic conditions. Hearts were isolated from 12-14-week-old obese male and female diabetic (db/db) mice versus lean non-diabetic littermates (db/+) controls. The Langendorff retrograde isolated heart perfusion system was employed to establish an ex vivo AHF model: a) Stabilization phase—Krebs Henseleit buffer (10 mM glucose) at 100 mmHg (25 min); b) Critical Acute Heart Failure (CAHF) phase–(1.2 mM palmitic acid, 2.5 mM glucose) at 20 mmHg (25 min); and c) Recovery Acute Heart Failure phase (RAHF)–(1.2 mM palmitic acid, 10 mM glucose) at 100 mmHg (25 min). Treated groups received 5 μM TMZ in the perfusate during either the CAHF or RAHF stage for the full duration of each respective phase. Both lean and obese males benefited from TMZ treatment administered during the RAHF phase. Sex differences were observed only in lean groups where the phases of the estrous cycle influenced therapy; only the lean follicular female group responded to TMZ treatment during the CAHF phase. Lean luteal females rather displayed an inherent cardioprotection (without treatments) that was lost with obesity. However, TMZ treatment initiated during RAHF was beneficial for obese luteal females. TMZ treatment triggered significant recovery for male and obese female hearts when administered during RAHF. There were no differences between lean and obese male hearts, while lean females displayed a functional recovery advantage over lean males. Thus TMZ emerges as a worthy therapeutic target to consider for AHF treatment in normal and obese-diabetic individuals (for both sexes), but only when administered during the recovery phase and not during the very acute stages." @default.
• W2647184575 created "2017-06-30" @default.
• W2647184575 creator A5037892267 @default.
• W2647184575 creator A5053743590 @default.
• W2647184575 creator A5087611127 @default.
• W2647184575 date "2017-06-20" @default.
• W2647184575 modified "2023-09-27" @default.
• W2647184575 title "Trimetazidine therapy for diabetic mouse hearts subjected to ex vivo acute heart failure" @default.
• W2647184575 cites W1483832212 @default.
• W2647184575 cites W1512733937 @default.
• W2647184575 cites W1556059509 @default.
• W2647184575 cites W1590767797 @default.
• W2647184575 cites W1832995858 @default.
• W2647184575 cites W1974139348 @default.
• W2647184575 cites W1980186143 @default.
• W2647184575 cites W1982830861 @default.
• W2647184575 cites W1988511720 @default.
• W2647184575 cites W1988720159 @default.
• W2647184575 cites W1990127475 @default.
• W2647184575 cites W1991385182 @default.
• W2647184575 cites W1992806887 @default.
• W2647184575 cites W1993823264 @default.
• W2647184575 cites W1998562191 @default.
• W2647184575 cites W2003061817 @default.
• W2647184575 cites W2008274522 @default.
• W2647184575 cites W2012244452 @default.
• W2647184575 cites W2012815042 @default.
• W2647184575 cites W2017331060 @default.
• W2647184575 cites W2017615202 @default.
• W2647184575 cites W2019882926 @default.
• W2647184575 cites W2021815263 @default.
• W2647184575 cites W2023731159 @default.
• W2647184575 cites W2025719851 @default.
• W2647184575 cites W2030721665 @default.
• W2647184575 cites W2032306546 @default.
• W2647184575 cites W2036764468 @default.
• W2647184575 cites W2037492221 @default.
• W2647184575 cites W2037662832 @default.
• W2647184575 cites W2038813835 @default.
• W2647184575 cites W2039801754 @default.
• W2647184575 cites W2042906643 @default.
• W2647184575 cites W2048764797 @default.
• W2647184575 cites W2050797798 @default.
• W2647184575 cites W2050856345 @default.
• W2647184575 cites W2054183115 @default.
• W2647184575 cites W2057313063 @default.
• W2647184575 cites W2058418796 @default.
• W2647184575 cites W2061490724 @default.
• W2647184575 cites W2065845561 @default.
• W2647184575 cites W2071792752 @default.
• W2647184575 cites W2086868392 @default.
• W2647184575 cites W2087503324 @default.
• W2647184575 cites W2099432828 @default.
• W2647184575 cites W2103270369 @default.
• W2647184575 cites W2110289049 @default.
• W2647184575 cites W2113697036 @default.
• W2647184575 cites W2115560327 @default.
• W2647184575 cites W2121836743 @default.
• W2647184575 cites W2123117529 @default.
• W2647184575 cites W2127780704 @default.
• W2647184575 cites W2128606426 @default.
• W2647184575 cites W2130917851 @default.
• W2647184575 cites W2135398118 @default.
• W2647184575 cites W2136709236 @default.
• W2647184575 cites W2137187865 @default.
• W2647184575 cites W2139088926 @default.
• W2647184575 cites W2141915279 @default.
• W2647184575 cites W2143445807 @default.
• W2647184575 cites W2143725549 @default.
• W2647184575 cites W2144192049 @default.
• W2647184575 cites W2148985060 @default.
• W2647184575 cites W2150810534 @default.
• W2647184575 cites W2153760325 @default.
• W2647184575 cites W2155962528 @default.
• W2647184575 cites W2159878423 @default.
• W2647184575 cites W2160969949 @default.
• W2647184575 cites W2162183126 @default.
• W2647184575 cites W2163218569 @default.
• W2647184575 cites W2164902492 @default.
• W2647184575 cites W2166323279 @default.
• W2647184575 cites W2166376702 @default.
• W2647184575 cites W2167018359 @default.
• W2647184575 cites W2168786365 @default.
• W2647184575 cites W2314382295 @default.
• W2647184575 cites W2416648371 @default.
• W2647184575 cites W2427094903 @default.
• W2647184575 cites W2467336920 @default.
• W2647184575 cites W2614170766 @default.
• W2647184575 cites W3021974182 @default.
• W2647184575 cites W4241857744 @default.
• W2647184575 cites W4292022394 @default.
• W2647184575 cites W4324263045 @default.
• W2647184575 cites W4378735534 @default.
• W2647184575 cites W4211200033 @default.
• W2647184575 doi "https://doi.org/10.1371/journal.pone.0179509" @default.
• W2647184575 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5478112" @default.
• W2647184575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28632748" @default.
• W2647184575 hasPublicationYear "2017" @default.

• next